Companies: 10,795·Total market cap: $144.5T
Abpro Corporation

Abpro Corporation

ABPNASDAQHealthcare
$0.52
+$0.00(+0.00%)
Market Cap$1057699
P/E Ratio
52W High$18.03
52W Low$0.11

Abpro Corporation (ABP) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

abp · pe ratio · data through Dec 31, 2024

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Abpro Corporation (ABP) measures how much investors pay for each dollar of the company's trailing earnings. ABP's current PE ratio of N/A is calculated by dividing its stock price of $0.52 by its TTM earnings per share of -$0.00.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31

Forward P/E
N/A
FY2026 est. EPS $-6.90
Based on 1 analyst
EPS (TTM)
-$0.00
TTM · diluted EPS
PEG Ratio
-9.42
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Abpro Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2016 – 2024 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Abpro Corporation
Abpro CorporationYou
ABP
$1MN/A-$0.00
AEON Biopharma, Inc.
AEON Biopharma, Inc.
AEON
$9MN/A-$3.95
Aptorum Group Limited
Aptorum Group Limited
APM
$8MN/A-$0.19
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.
BOLT
$9MN/A-$17.85
Cingulate Inc.
Cingulate Inc.
CING
$25MN/A-$4.13
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc.
CLRB
$8MN/A-$8.35
Evogene Ltd.
Evogene Ltd.
EVGN
$5MN/A-$1.08

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2024-12-31Latest
FY2024
$-23.09
2023-12-31
FY2023
$-37.53
2022-12-31
FY2022
$-55.46
2021-12-31
FY2021
$-47.67
2017-12-31
FY2017
$-31.51
2016-12-31
FY2016
$-14.21

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Abpro Corporation (ABP) measures how much investors pay for each dollar of the company's trailing earnings. ABP's current PE ratio of N/A is calculated by dividing its stock price of $0.52 by its TTM earnings per share of -$0.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.52 ÷ -$0.00 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ABP pe ratio · 6 questions

ABP's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.52 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via ABP's SEC 10-K and 10-Q filings.

ABP PE ratioWhat is ABP PE ratioCurrent PE ratio of ABPABP PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Abpro Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08